EP4252857
METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.9.2012EP published:
25.9.2024EP application number:
23176223.8
EPO information:
European Patent Register
Max expiry date:
11.9.2032
Title in English:
METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)Language of the patent:
English
Timeline
Today
12.9.2012EP application
25.9.2024EP Publication
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6706, US
Inventor
Name:
SWERGOLD, GaryAddress:
New Rochelle, NY 10804, US
Priority
Number:
201161535392 PDate:
16.9.2011Country:
US
Number:
201161559162 PDate:
14.11.2011Country:
US
Number:
201261641321 PDate:
2.5.2012Country:
US
Classification
Categories:
C07K 16/40, A61P 3/06, A61K 39/00, A61P 7/00, A61P 9/00, A61P 9/10, A61P 11/00, A61P 27/02, A61P 43/00